Matches in SemOpenAlex for { <https://semopenalex.org/work/W1546563847> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W1546563847 endingPage "22" @default.
- W1546563847 startingPage "13" @default.
- W1546563847 abstract "Abstract Two hundred fifty-two previously untreated evaluable patients with multiple myeloma were entered into a study testing a regimen of three intravenous alkylating agents, melphalan, cyclophosphamide, and carmustine (BCNU), given in combination (BCMP) against a regimen employing oral melphalan (MP). Both regimens included a tapering course of prednisone. Objective responses based on the Myeloma Task Force criteria were significantly more frequent in the group receiving BCMP. Survival for the entire group of BCMP-treated patients was not significantly better than that for MP-treated patients (p = 0.62). However, when the survival of the poor-risk (high tumor cell load) group of patients treated with BCMP was compared with the survival of the poor-risk (high tumor cell load) group of patients treated with MP, an improvement in survival attributable to BCMP therapy was seen (p = 0.049 and 0.02, respectively). In the good-risk (low and intermediate tumor cell load) group, BCMP treatment resulted in a trend toward poorer survival, but this did not achieve statistical significance (p = 0.080 and 0.23, respectively). These results indicate that optimal therapy in myeloma may be dependent on the extent of disease at the time of first treatment. Additional studies to explore the effects of treatment intensity and duration are needed in order to design improved myeloma treatment based on the patient's extent of disease." @default.
- W1546563847 created "2016-06-24" @default.
- W1546563847 creator A5025566532 @default.
- W1546563847 creator A5031875226 @default.
- W1546563847 creator A5033884661 @default.
- W1546563847 creator A5040981514 @default.
- W1546563847 creator A5046383113 @default.
- W1546563847 creator A5053035542 @default.
- W1546563847 creator A5082720713 @default.
- W1546563847 date "1979-07-01" @default.
- W1546563847 modified "2023-09-27" @default.
- W1546563847 title "Improved survival of increased-risk myeloma patients on combined triple- alkylating-agent therapy: a study of the CALGB" @default.
- W1546563847 cites W1487954024 @default.
- W1546563847 cites W1580788756 @default.
- W1546563847 cites W2000538996 @default.
- W1546563847 cites W2006382315 @default.
- W1546563847 cites W2037355300 @default.
- W1546563847 cites W2040903318 @default.
- W1546563847 cites W2042698085 @default.
- W1546563847 cites W2070682538 @default.
- W1546563847 cites W2079708060 @default.
- W1546563847 cites W2082410795 @default.
- W1546563847 cites W2273737858 @default.
- W1546563847 cites W2312337520 @default.
- W1546563847 cites W2324498160 @default.
- W1546563847 cites W2389204473 @default.
- W1546563847 cites W2401678079 @default.
- W1546563847 cites W2414997527 @default.
- W1546563847 cites W2415881414 @default.
- W1546563847 cites W3125714968 @default.
- W1546563847 doi "https://doi.org/10.1182/blood.v54.1.13.13" @default.
- W1546563847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/444661" @default.
- W1546563847 hasPublicationYear "1979" @default.
- W1546563847 type Work @default.
- W1546563847 sameAs 1546563847 @default.
- W1546563847 citedByCount "93" @default.
- W1546563847 countsByYear W15465638472023 @default.
- W1546563847 crossrefType "journal-article" @default.
- W1546563847 hasAuthorship W1546563847A5025566532 @default.
- W1546563847 hasAuthorship W1546563847A5031875226 @default.
- W1546563847 hasAuthorship W1546563847A5033884661 @default.
- W1546563847 hasAuthorship W1546563847A5040981514 @default.
- W1546563847 hasAuthorship W1546563847A5046383113 @default.
- W1546563847 hasAuthorship W1546563847A5053035542 @default.
- W1546563847 hasAuthorship W1546563847A5082720713 @default.
- W1546563847 hasBestOaLocation W15465638471 @default.
- W1546563847 hasConcept C126322002 @default.
- W1546563847 hasConcept C141071460 @default.
- W1546563847 hasConcept C143998085 @default.
- W1546563847 hasConcept C2776364478 @default.
- W1546563847 hasConcept C2776694085 @default.
- W1546563847 hasConcept C2776755627 @default.
- W1546563847 hasConcept C2778684742 @default.
- W1546563847 hasConcept C2778720950 @default.
- W1546563847 hasConcept C2780147359 @default.
- W1546563847 hasConcept C2781413609 @default.
- W1546563847 hasConcept C71924100 @default.
- W1546563847 hasConceptScore W1546563847C126322002 @default.
- W1546563847 hasConceptScore W1546563847C141071460 @default.
- W1546563847 hasConceptScore W1546563847C143998085 @default.
- W1546563847 hasConceptScore W1546563847C2776364478 @default.
- W1546563847 hasConceptScore W1546563847C2776694085 @default.
- W1546563847 hasConceptScore W1546563847C2776755627 @default.
- W1546563847 hasConceptScore W1546563847C2778684742 @default.
- W1546563847 hasConceptScore W1546563847C2778720950 @default.
- W1546563847 hasConceptScore W1546563847C2780147359 @default.
- W1546563847 hasConceptScore W1546563847C2781413609 @default.
- W1546563847 hasConceptScore W1546563847C71924100 @default.
- W1546563847 hasIssue "1" @default.
- W1546563847 hasLocation W15465638471 @default.
- W1546563847 hasOpenAccess W1546563847 @default.
- W1546563847 hasPrimaryLocation W15465638471 @default.
- W1546563847 hasRelatedWork W138225822 @default.
- W1546563847 hasRelatedWork W1978247579 @default.
- W1546563847 hasRelatedWork W2022680061 @default.
- W1546563847 hasRelatedWork W2059403857 @default.
- W1546563847 hasRelatedWork W2400982915 @default.
- W1546563847 hasRelatedWork W2408784808 @default.
- W1546563847 hasRelatedWork W2413876151 @default.
- W1546563847 hasRelatedWork W2461525907 @default.
- W1546563847 hasRelatedWork W274483042 @default.
- W1546563847 hasRelatedWork W4245617834 @default.
- W1546563847 hasVolume "54" @default.
- W1546563847 isParatext "false" @default.
- W1546563847 isRetracted "false" @default.
- W1546563847 magId "1546563847" @default.
- W1546563847 workType "article" @default.